abstract |
The present invention relates to novel retinoid-related orphan receptor gamma (RORĪ³) modulators, methods for their production, pharmaceutical compositions containing these modulators, and inflammatory, metabolic and autoimmune diseases mediated by RORĪ³. Intended for their use in the treatment of |